Grounded in the data
Medical review stays aligned with the numbers coming out of biostatistics and data management — no surprises between the listings and the review.
Service → Milestone → Deliverable
Select a milestone to see what we deliver at that point in the study.
Why NoyMed
Anyone can staff a medical monitor. Sponsors choose the team behind the judgment calls — how consistent the review criteria are, how fast safety signals get clinical eyes, and how directly medical input carries through to the CSR and the publication record.
Medical review stays aligned with the numbers coming out of biostatistics and data management — no surprises between the listings and the review.
Signal management and safety review run in step with pharmacovigilance, not bolted on after the fact.
Medical input feeds straight into the CSR and publication plan — no reconciliation step.
Medical review guidelines applied the same way across every investigator, not left to individual interpretation.
Advisory boards and KOL engagement managed as an ongoing relationship, not a single transactional touchpoint.
Medical monitoring plans, review logs, and correspondence pass through the same quality assurance review as every other deliverable.
Beyond the standard deliverables
Agency-facing regulatory support that doesn't map to a single milestone — available as standalone engagements or layered onto a full study team.
Pre-IND consulting and IND application support, getting agency alignment before the clock starts.
Agency communication tracked end to end, alongside broader regulatory affairs strategy across Phase I-IV.
NDA support, coordinating documents for the marketing application.
What sponsors say
Common questions
What sponsors typically ask before handing over medical monitoring and scientific communication.
Tell us your study phase, therapeutic area, and timeline — we'll walk through how our medical affairs team plugs in.